GLP-1 receptor agonists have transformed the management of type 2 diabetes (T2DM) and obesity. These drugs have been demonstrated to improve glycemic management, reduce body weight, and reduce the risk of cardiovascular events. This blog will investigate glucagon-like peptide-1 inhibitors, including their mechanism of action, advantages, and potential adverse effects. What is GLP-1? Glucagon-like peptide-1 […]